210 related articles for article (PubMed ID: 37236761)
1. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
Spite M; Fredman G
Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
[TBL] [Abstract][Full Text] [Related]
2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
3. Specialized pro-resolving mediators in cardiovascular diseases.
Fredman G; Spite M
Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
[TBL] [Abstract][Full Text] [Related]
5. Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders.
Honkisz-Orzechowska E; Łażewska D; Baran G; Kieć-Kononowicz K
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542895
[TBL] [Abstract][Full Text] [Related]
6. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
[TBL] [Abstract][Full Text] [Related]
7. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
[TBL] [Abstract][Full Text] [Related]
8. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
9. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
[TBL] [Abstract][Full Text] [Related]
10. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M
Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
[TBL] [Abstract][Full Text] [Related]
12. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
Recchiuti A; Serhan CN
Front Immunol; 2012; 3():298. PubMed ID: 23093949
[TBL] [Abstract][Full Text] [Related]
13. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Fredman G
Front Pharmacol; 2019; 10():205. PubMed ID: 30899222
[TBL] [Abstract][Full Text] [Related]
14. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
Satish M; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease.
Pirault J; Bäck M
Front Pharmacol; 2018; 9():1273. PubMed ID: 30487747
[TBL] [Abstract][Full Text] [Related]
17. Pro-resolution therapeutics for cardiovascular diseases.
Heinz J; Marinello M; Fredman G
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
[TBL] [Abstract][Full Text] [Related]
18. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
[TBL] [Abstract][Full Text] [Related]
19. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
20. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
